2m 2m 2m 2m 2m 2m 2m
CELULARITY-A (CELU)
NASDAQ
$1.02-$0.004 (-0.39%)
Price as of Jun 03, 2026 4:13 PM EDT- $29.2MMarket Cap
- -54.31%1-Year Change
- BiotechnologyIndustry
CELULARITY-A (CELU)
$1.02-$0.004 (-0.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 13.2M -62.72% | 35.3M +55.18% | 22.8M +26.68% | 18.0M -15.75% | |
Cost of Revenue | 13.2M -16.53% | 15.8M -1.30% | 16.0M -18.56% | 19.7M +103.72% | |
Gross Profit | -19,000 -100.10% | 19.5M +189.10% | 6.8M +499.70% | -1.7M -114.47% | |
Sales and Marketing Expense | 51.3M -12.58% | 58.6M +15.95% | 50.6M -23.39% | 66.0M -7.46% | |
Research and Development Expense | -15.0M -13.58% | -17.4M -42.93% | -30.5M -61.12% | -78.4M -11.31% | |
Depreciation and Amortization Expense | 7.3M -7.91% | 7.9M -15.04% | 9.3M -1.19% | 9.4M +7.02% | |
Total Operating Expenses | 51.3M -12.58% | 58.6M +15.95% | 50.6M -23.39% | 66.0M -7.46% | |
Operating Profit | -61.3M +59.83% | -38.4M -80.05% | -192.3M +651.12% | -25.6M -76.53% | |
Interest Income | 262,000 -20.85% | 331,000 +3.44% | 320,000 -12.33% | 365,000 +9.94% | |
Interest Expense | -685,000 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -423,000 -227.79% | 331,000 +3.44% | 320,000 -12.33% | 365,000 +9.94% | |
Total Nonoperating Income and Expense | -30.4M +55.65% | -19.5M +388.59% | -4.0M -110.04% | 39.8M +344.20% | |
Income before Taxes | -91.7M +58.42% | -57.9M -70.51% | -196.3M -1,481.80% | 14.2M +114.19% | |
Income Taxes | 3,000 N/A | N/A N/A | 10,000 -23.08% | 13,000 -35.00% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -91.8M +58.56% | -57.9M -70.51% | -196.3M -1,483.14% | 14.2M +114.18% | |
Net Income from Continuing Operations Applicable to Common | -91.8M +58.57% | -57.9M -70.51% | -196.3M -1,481.80% | 14.2M +114.19% | |
Basic EPS and Net Income | -3.59 +35.98% | -2.64 -76.04% | -11.02 -11,120.00% | 0.10 +106.71% | |
Diluted EPS and Net Income | -3.59 +35.98% | -2.64 -76.04% | -11.02 -12,344.44% | 0.09 +106.04% | |
Basic Weighted Average Shares | 25.6M +16.94% | 21.9M +22.89% | 17.8M -87.27% | 139.9M +108.64% | |
Diluted Weighted Average Shares | 25.6M +16.94% | 21.9M +22.89% | 17.8M -88.11% | 149.8M +123.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.2M +736.72% | 738,000 +225.11% | 227,000 -98.37% | 14.0M -62.50% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.2M +736.72% | 738,000 +225.11% | 227,000 -98.37% | 14.0M -62.50% | |
Total Current Assets | 12.3M -40.09% | 20.6M +3.88% | 19.8M -40.92% | 33.5M -43.31% | |
Accumulated Depreciation | 38.7M +17.66% | 32.9M +20.49% | 27.3M +34.17% | 20.3M +37.57% | |
Property and Plant and Equipment and Net | 55.8M -9.42% | 61.6M -9.18% | 67.8M -10.35% | 75.7M -16.52% | |
Total Long-Term Assets | 247,000 -8.52% | 270,000 -19.88% | 337,000 -10.37% | 376,000 +5.92% | |
Total Assets | 107.3M -19.11% | 132.7M -7.79% | 143.9M -64.12% | 401.1M -3.15% | |
Income Taxes Payable | 12,000 +33.33% | 9,000 0.00% | 9,000 0.00% | 9,000 -10.00% | |
Total Short-Term Debt | 9.6M +284.83% | 2.5M -85.57% | 17.2M -54.20% | 37.6M N/A | |
Total Current Liabilities | 80.8M +50.45% | 53.7M -20.24% | 67.3M +8.39% | 62.1M +136.75% | |
Total Long-Term Debt | 39.7M +10.60% | 35.9M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 266,000 -5.00% | 280,000 -4.76% | 294,000 -8.41% | 321,000 -4.18% | |
Total Liabilities | 145.4M +17.40% | 123.8M +20.32% | 102.9M -49.09% | 202.2M -35.76% | |
Retained Earnings | -991.5M +10.20% | -899.7M +6.88% | -841.8M +30.41% | -645.5M -2.74% | |
Total Stockholders Equity | 1.3M -85.78% | 8.8M -78.43% | 41.0M -79.41% | 198.9M +100.07% | |
Total Shares Outstanding | 28.8M +27.90% | 22.5M +16.35% | 19.4M -86.99% | 148.9M +19.80% | |
Cash Flow | |||||
Cash from Operating Activities | -13.3M +107.06% | -6.4M -83.45% | -38.7M -71.94% | -137.9M +25.23% | |
Capital Expenditures | N/A N/A | 161,000 -84.64% | 1.0M -79.98% | 5.2M -15.59% | |
Cash from Investing Activities | N/A N/A | 514,000 +112.70% | -4.0M -22.69% | -5.2M -11.30% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 18.6M +178.30% | 6.7M -72.19% | 24.1M -79.89% | 119.8M +21.59% | |
Financials Ratio | |||||
Gross Margin | -0.14% -100.26% | 55.27% +86.30% | 29.66% +415.52% | -9.40% -117.17% | |
Operating Margin | -465.34% +328.67% | -108.55% -87.15% | -844.44% +492.92% | -142.42% -72.14% | |
Return on Assets | -76.50% +82.71% | -41.87% -41.88% | -72.04% -2,169.01% | 3.48% +112.28% | |
Return on Equity | -1,818.90% +682.22% | -232.53% +42.07% | -163.67% -1,820.24% | 9.51% +104.96% | |
Revenue Growth | -62.72% -213.66% | 55.18% +106.81% | 26.68% +269.42% | -15.75% N/A | |
Current Ratio | 0.15 -60.18% | 0.38 +30.23% | 0.29 -45.50% | 0.54 -76.06% | |
Cash Ratio | 0.08 +458.39% | 0.01 +302.94% | 0.003 -98.49% | 0.22 -84.16% | |
Debt-to-Equity Ratio | 39.22 +802.25% | 4.35 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.46 +58.65% | 0.29 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow